Omnaris and Para drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Omnaris (ciclesonide) and Para (para - aminobenzoic acid (paba)). Common drug interactions include inflammatory bowel disease among males.
The phase IV clinical study analyzes what interactions people have when they take Omnaris and Para. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.
What is Omnaris?
Omnaris has active ingredients of ciclesonide. It is often used in allergies. eHealthMe is studying from 3,970 Omnaris users. Check the latest studies of Omnaris.
What is Para?
Para has active ingredients of para - aminobenzoic acid (paba). eHealthMe is studying from 2,194 Para users. Check the latest studies of Para.
15 people who take Omnaris and Para together, and have interactions are studied.
What are the common drug interactions of Omnaris and Para, by gender? *:
female:
n/a
male:
- Inflammatory bowel disease
- Appetite disorder (abnormal eating habits)
- Diarrhoea
- Fatigue (feeling of tiredness)
- Insomnia (sleeplessness)
- Post procedural haemorrhage (post procedural bleeding)
- Tonsil cancer
What are the common drug interactions of Omnaris and Para, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Inflammatory bowel disease
30-39:
n/a
40-49:
n/a
50-59:
- Fatigue (feeling of tiredness)
- Insomnia (sleeplessness)
- Post procedural haemorrhage (post procedural bleeding)
60+:
- Appetite disorder (abnormal eating habits)
- Diarrhoea
- Tonsil cancer
What are the existing conditions these people have? *
- Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 14 people, 93.33%
- Nausea (feeling of having an urge to vomit): 9 people, 60.00%
* Approximation only. Some reports may have incomplete information.
Do you take Omnaris and Para?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Omnaris and Para:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Omnaris:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Para:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Omnaris and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Para and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on ciclesonide and para - aminobenzoic acid (paba) (the active ingredients of Omnaris and Para, respectively), and Omnaris and Para (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Aricept and Nitroglycerin - 3 seconds ago
- Drug interactions of Proscar and Prilosec - 5 seconds ago
- Drug interactions of Omnaris and Wixela Inhub - 6 seconds ago
- Drug interactions of Trileptal and Pantoprazole Sodium - 11 seconds ago
- Could Xtampza Er cause Pneumonia? - 18 seconds ago
- Drug interactions of Myrbetriq and Calcium Citrate - 23 seconds ago
- Drug interactions of Vitamin D and Melphalan - 31 seconds ago
- Could Metoprolol Tartrate cause X-Ray Abnormal? - 40 seconds ago
- Drug interactions of Benzonatate and Mounjaro - 41 seconds ago
- Drug interactions of Advair Hfa and Proamatine - 48 seconds ago